2010 Focused Update of ESC Guidelines on Device Therapy in Heart Failure

[1]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[2]  R. Hetzer,et al.  Mechanical circulatory support in patients of advanced age , 2010, European journal of heart failure.

[3]  P. Brugada,et al.  Long‐Term Effects of Upgrading to Biventricular Pacing: Differences with Cardiac Resynchronization Therapy as Primary Indication , 2010, Pacing and clinical electrophysiology : PACE.

[4]  Jeroen J. Bax,et al.  Effects of cardiac resynchronisation therapy in patients with heart failure having a narrow QRS Complex enrolled in PROSPECT , 2010, Heart.

[5]  B. Billah,et al.  Extending the boundaries of cardiac resynchronization therapy: efficacy in atrial fibrillation, New York heart association class II, and narrow QRS heart failure patients. , 2010, Journal of cardiac failure.

[6]  L. Lund,et al.  Patient selection for left ventricular assist devices , 2010, European journal of heart failure.

[7]  J. Daubert,et al.  Resumption of sinus rhythm in patients with heart failure and permanent atrial fibrillation undergoing cardiac resynchronization therapy: a longitudinal observational study. , 2010, European heart journal.

[8]  Kevin Vernooy,et al.  Beneficial effects of biventricular pacing in chronically right ventricular paced patients with mild cardiomyopathy. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[9]  M. Messier,et al.  Prevalence and risk factors related to infections of cardiac resynchronization therapy devices. , 2010, European heart journal.

[10]  Robert L Kormos,et al.  Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  S. Russell,et al.  Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.

[12]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[13]  Cheuk-Man Yu,et al.  Biventricular pacing in patients with bradycardia and normal ejection fraction. , 2009, The New England journal of medicine.

[14]  K. Dickstein,et al.  Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008 , 2009, European journal of heart failure.

[15]  M. Gold,et al.  Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. , 2009, Journal of the American College of Cardiology.

[16]  K. Dickstein,et al.  The European cardiac resynchronization therapy survey. , 2009, European heart journal.

[17]  Nader Moazami,et al.  Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. , 2009, Journal of the American College of Cardiology.

[18]  N. Freemantle,et al.  Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub‐analysis of the CARE‐HF trial , 2009, European journal of heart failure.

[19]  R. Sutton,et al.  Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices. , 2009, The American journal of cardiology.

[20]  S. A. Christman,et al.  Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary? , 2009, Journal of the American College of Cardiology.

[21]  S. Connolly,et al.  Resynchronization/defibrillation for ambulatory heart failure trial: rationale and trial design , 2009, Current opinion in cardiology.

[22]  Stefano Ghio,et al.  Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. , 2008, Journal of the American College of Cardiology.

[23]  Jagmeet P. Singh,et al.  Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. , 2008, Journal of the American College of Cardiology.

[24]  Michael Böhm,et al.  Kommentar zu den ESC-Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 , 2008, European journal of heart failure.

[25]  A. Ferreira,et al.  Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[26]  M. Metra,et al.  Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation , 2008, European heart journal.

[27]  M. Frenneaux,et al.  Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation , 2008, Heart.

[28]  M. Allessie,et al.  Management of atrial fibrillation in patients with heart failure. , 2007, European heart journal.

[29]  A. Owen,et al.  Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials , 2007, BMJ : British Medical Journal.

[30]  J. Daubert,et al.  Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. , 2007, European heart journal.

[31]  J. Ottervanger,et al.  Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure. , 2007, The American journal of cardiology.

[32]  Leslie Saxon,et al.  Effects of Cardiac Resynchronization Therapy With or Without a Defibrillator on Survival and Hospitalizations in Patients With New York Heart Association Class IV Heart Failure , 2006, Circulation.

[33]  Jeroen J. Bax,et al.  Cardiac resynchronization therapy in patients with a narrow QRS complex. , 2006, Journal of the American College of Cardiology.

[34]  Eric Boersma,et al.  Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. , 2006, European heart journal.

[35]  Catherine Klersy,et al.  Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. , 2006, Journal of the American College of Cardiology.

[36]  Nick Freemantle,et al.  Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. , 2006, European heart journal.

[37]  Michael Böhm,et al.  Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the Homburg Biventricular Pacing Evaluation (HOBIPACE). , 2006, Journal of the American College of Cardiology.

[38]  J. Daubert,et al.  Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular , 2006, American heart journal.

[39]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[40]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[41]  J. Schroeder,et al.  Effects of Cardiac Resynchronization on Disease Progression in Patients With Left Ventricular Systolic Dysfunction, an Indication for an Implantable Cardioverter-Defibrillator, and Mildly Symptomatic Chronic Heart Failure , 2004, Circulation.

[42]  Lisa Hartling,et al.  Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart Failure , 2004, Annals of Internal Medicine.

[43]  J. Daubert.  Introduction to atrial fibrillation and heart failure: a mutually noxious association. , 2004, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[44]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[45]  E. Foster,et al.  Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. , 2003, Journal of the American College of Cardiology.

[46]  R. Canby,et al.  Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. , 2003, JAMA.

[47]  S. Goodman,et al.  Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. , 2003, JAMA.

[48]  J. Daubert,et al.  Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. , 2002, European heart journal.

[49]  A. Maggioni,et al.  Cumulative effect of complete left bundle-branch block and chronic atrial fibrillation on 1-year mortality and hospitalization in patients with congestive heart failure. A report from the Italian network on congestive heart failure (in-CHF database). , 2002, European heart journal.

[50]  Thomas Lavergne,et al.  Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. , 2002, Journal of the American College of Cardiology.

[51]  Stefan Sack,et al.  Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. , 2002, Journal of the American College of Cardiology.

[52]  D. Delurgio,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[53]  Simon Capewell,et al.  The current cost of heart failure to the National Health Service in the UK , 2002, European journal of heart failure.

[54]  Luigi Tavazzi,et al.  Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. , 2002, American heart journal.

[55]  M. Block,et al.  Pacing Therapies in Congestive Heart Failure II study. , 2000, The American journal of cardiology.

[56]  F. Gaita,et al.  Performance of a New Steroid‐Eluting Coronary Sinus Lead Designed for Left Ventricular Pacing , 2000, Pacing and clinical electrophysiology : PACE.